Our Neuron DDS is designed to deliver therapeutic molecules to neurons. We are developing pipelines for ALS, as well as expanding the delivery platform to other neurodegenerative and neurological diseases.
| Indication | Payload modality | Discovery | Preclinical | Phase I | Phase II | Phase III |
|---|---|---|---|---|---|---|
| familial ALS | Oligonucleotide | |||||
| sporadic ALS | Small molecule | |||||
| Neurodegenerative diseases |
undisclosed | |||||